The Food and Drug Administration (FDA) is moving ahead with a safety review of the abortion pill mifepristone, according to an administration official. The move marks a victory for anti-abortion groups that could pave the way for the Trump administration to restrict its use and how it can be distributed. The retrospective analysis of data…
Politics
·
FDA reviewing safety of abortion drug mifepristone
CN
CitrixNews Staff
Originally reported by The Hill
Related Articles
Politics
Chuck Schumer Privately Backs Haley Stevens in Michigan Democratic Senate Primary
Chuck Schumer, the Democratic minority leader, has remained officially neutral on the race, but in conversations with do...
CitrixNews Staff
·
25 minutes ago
Politics
Judge Says Trump Officials Must Restart Asylum and Immigration Processing
The judge invalidated policies the Trump administration enacted last year that halted asylum grants, as well as the proc...
CitrixNews Staff
·
26 minutes ago
Politics
Platner says he and wife dealt with his texts to other women ‘very early’ in marriage
Maine Senate hopeful Graham Platner (D) said Thursday that his past sexting with multiple women was an issue that he and...
CitrixNews Staff
·
42 minutes ago
Politics
House GOP moves to codify Hegseth’s ‘Department of War’ name change
Republicans on the House Armed Services Committee moved to codify Defense Secretary Pete Hegseth’s “Department of War” n...
CitrixNews Staff
·
48 minutes ago